Delivering optimal adjuvant chemotherapy in primary breast cancer: the role of rHuG-CSF

By Paridaens R.   Lyman G.H.   Leonard R.   Crawford J.   Bosly A.   Constenla M.   Jackisch C.   Pettengell R.   Szucs T.   on behalf of the Impact of Neutropenia in Chemotherapy European Study Group  

EJC Supplements, Vol. 1, Iss. 9, 2003-11 ,pp. : 1-12

Elsevier

Access to resources Recommend Favorite

Timely Withdrawal of G-CSF Reduces the Occurrence of Thrombocytopenia During Dose-dense Chemotherapy

By Timmer-Bonte J.N.H.   Mulder P.H.M.   Peer P.G.M.   Beex L.V.A.M.   Tjan-Heijnen V.C.G.  

Breast Cancer Research and Treatment, Vol. 93, Iss. 2, 2005-09 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite

A Randomised Study Comparing Granulocyte-colony Stimulating Factor (G-CSF) with G-CSF Plus Thymostimulin in the Treatment of Haematological Toxicity in Patients with Advanced Breast Cancer after High Dose Mitoxantrone Therapy

By Sanchiz F.   Milla A.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

By Shikata Hisaharu   Yakushijin Yoshihiro   Yamanouchi Jun   Azuma Taichi   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 178-185

Springer Publishing Company

Access to resources Recommend Favorite

Role of HuR in keratinocyte migration and wound healing

By        

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 529-534

Spandidos Publications

Access to resources Recommend Favorite